Research

The Golden research group uses synthetic medicinal chemistry to address issues in chemical biology. We develop synthetic methods to generate new chemical architecture and explore its associated pharmacology. Currently, projects in my laboratory focus on chemical methodology development and the optimization of anti-infective and anticancer agents in cell and animal models. We work closely with expert collaborators who assess our compounds against various biological targets, and through structural manipulation of our chemical scaffolds, we refine properties to achieve a desired activity profile. As such, synthetic and medicinal chemistry go hand-in-hand, as we develop novel synthetic transformations that afford distinct, drug-like architecture that permit exploration of underrepresented scaffolds.

Synthetic Methodology

Diagram of the Exploration of a novel quinazolinone rearrangement

Diagram of Telescoped Assembly of E-Carbo/Oxo-Amidines Via Alkylquinazolinone Rearrangement

Diagram of Divergetnt Rearrangement: Twisted-Cyclic Guanidine Formulation or Ring-Fused N-Acylguanidines

diagram of Cyclocarbonylation of Aminopyridine-Linked Vinylogous Amides and Ureas

Diagram of Ring-Fused, N-Substituted 4-Quinolinones via pKa-Guided, Base-Promoted Annulations

Medicinal Chemistry

Short synapsis and Infographic of Development of Small Molecule Inhibitors of Encephalatic Alphaviruses

Infographic and synopsis of Inhibitors of Naneglaria fowleri ("brain eating" amoeba)

Screenshot of Inhibitors of Kinetoplastid and Persistent Toxoplasma Parasites including three images of microorganisms and a brief discription.